Ensuring the Sustainability of ARVs: Critical Issues in the Success of National ARV Treatment Programs in Asia. TREAT ASIA and amfAR (2006)

Ensuring the Sustainability of ARVs: Critical Issues in the Success of National ARV Treatment Programs in Asia. TREAT ASIA and amfAR (2006) This is a presentation on Critical Issues in the Success of National ARV Treatment Programs in Asia. The presentation was made by Director Kevin Robert Frost of TREAT Asia.

Download this publication

Management of HIV Infection and Antiretroviral Therapy in Infants and Children: A Clinical Manual. WHO and UNICEF (2006)

Management of HIV Infection and Antiretroviral Therapy in Infants and Children: A Clinical Manual. WHO and UNICEF (2006) These guidelines are based on the discussions held with health-care workers, researchers and programme managers from South-East Asia during a regional consultation organized by the World Health Organization Regional Office for South-East Asia (WHO SEARO) and the United Nations Children's Fund Regional Office for South Asia (UNICEF ROSA) in New Delhi during 2006. This consultation meeting reviewed the new data, experiences of scaling-up of pediatric ART in the Region and made recommendations for adaptation to the needs in the Region of the global WHO guidelines on Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access. To facilitate use at the country level the consultation recommended simplification of the global guidelines.

Download this publication

Management of HIV Infection and Antiretroviral Therapy in Infants and Children: A Clinical Manual. WHO and UNICEF (2006)

Management of HIV Infection and Antiretroviral Therapy in Infants and Children: A Clinical Manual. WHO and UNICEF (2006) Successful scaling-up of antiretroviral therapy (ART) requires rational use of antiretroviral (ARV) drugs. These simplified and standardized guidelines on the appropriate and rational use of ART in resource- limited settings for South and South-East Asia are intended as a resource for

Download this publication

Success and Failure at 24 Months of HAART in a Resource-poor Setting: Observational Cohort of 416 HIV-Treated Patients. Epicentre and Medecins Sans Frontiers (2006)

Success and Failure at 24 Months of HAART in a Resource-poor Setting: Observational Cohort of 416 HIV-Treated Patients. Epicentre and MEDECINS SANS FRONTIERS (2006) Main objective • Retrospective cohort analysis of patients who started ARV 24 + 2 months ago and followed without viral load monitoring Secondary objectives • Description of success/failure clinico-immunological criteria at 24 months and at 6, 12 and 18 months • Identification of the reasons for virological failure at 24 months • Description of resistance mutations to ARV observed at 24 months • Analysis of the observance of the patients still on ARV at 24 months • Evaluation of ARV side-effects during the 24 months of treatment • Pharmacological analysis of ARV at 24 months

Download this publication

AIDS and Social Policy in China: Harvard University Asia Center Cambridge, Massachusetts. Kaufman J, Kleinman A and Saich T (Eds.) (2006)

AIDS and Social Policy in China: Harvard University Asia Center Cambridge, Massachusetts. Kaufman J, Kleinman A and Saich T (Eds.) (2006) It is hard to avoid making grand statements when writing about AIDS and China, especially now that news magazines across the globe speak of the twenty-first century as “the Chinese century.” Even without the hyperbole, how the world’s most populous nation responds to AIDS obviously has great consequences for the future of public health. That future is, of course, difficult to predict: witness the brave hopes voiced three decades ago when the Chinese delegation took part in the signing of the famous Declaration of Alma Ata, which proclaimed the goal of “health for all by the year 2000.” That vision of the future does not look much like our present, either in China or elsewhere.

Download this publication

Antiretroviral Therapy for HIV Infection in Adults and Adolescents in Resource-Limited Settings: Towards Universal Access. WHO (2006)

Antiretroviral Therapy for HIV Infection in Adults and Adolescents in Resource-Limited Settings: Towards Universal Access. WHO (2006) By the end of 2005 the World Health Organization estimated that there were just over 1.3 million people receiving antiretroviral therapy (ART) in low-income and middle-income countries, representing 20% of the 6.5 million estimated to need it. Since the need to close the treatment gap was declared a global public health emergency, and the launch of the “3 by 5” initiative by WHO and UNAIDS in December 2003, the number of people receiving ART has more than tripled.


Download this publication

Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection In Infants In Resource-Limited Settings: Towards Universal Access. WHO (2006)

Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection In Infants In Resource-Limited Settings: Towards Universal Access. WHO (2006) resistance to hiV drugs may emerge in women receiving triple-combination regimens but occurs more frequently with single- and dual-drug regimens. Viral resistance is a potential problem for women after short-term exposure to arV drug regimens to prevent mtct and for infants who become infected. this is particularly the case for nVp and 3tc, drugs for which a single mutation leads to high-level resistance, whereas multiple sequential mutations are needed to confer resistance to azt.

Download this publication

The Changing Role of Home Based The Changing Role of Home Based Care in Cambodia in the Era of ART. Sovannarith, S (2006)

The Changing Role of Home Based The Changing Role of Home Based Care in Cambodia in the Era of ART. Sovannarith, S (2006) Background of HBC in Cambodia
␣␣ In 1998, joint pilot project on HBC in Phnom Penh by NCHADS, Municipal Health Department, WHO, and 8 NGO
␣␣ End of 1998, evaluation of the pilot project by NCHADS and WHO
␣␣ In 1999, expansion of HBC to Battambang province

Download this publication

Cambodia Expanding the Continuum of Care to Children. National Centre for HIV/AIDS Dermatology and STD Cambodia (2006)

Cambodia Expanding the Continuum of Care to Children. National Centre for HIV/AIDS Dermatology and STD Cambodia (2006) Current reports place the HIV prevalence rate in Cambodia at 1.9% 1of the general population. Although this is small compared with many nations in sub-Saharan Africa, it is the highest sero- prevalence in the South-east Asia region. It is noteworthy that this rate has actually declined over the past five years – which is a testament to the political commitment of the Government of Cambodia and the success of HIV prevention programs that have resulted in almost universal acceptance of condom usage.

Download this publication

A Comprehensive Intervention Based on Peer Education for Injecting Drug Users in Lang Son. Ngu D, Duy N, Son NT, et al (2006)

A Comprehensive Intervention Based on Peer Education for Injecting Drug Users in Lang Son. Ngu D, Duy N, Son NT, et al (2006) This is a presentation on results obtained from the implementation of the project, "A comprehensive intervention based on peer education for injecting drug users" in Lang Son. The objective of this project is to restrain HIV/AIDS epidemic within IDUs and from this group in to community in Lamg Son.

Download this publication

Pages

Data Dashboard
database
Highlighted publications
https://aidsdatahub.org/sites/default/files/highlight-reference/document/ESCAP_Asia_and_the_Pacific_SDG_Progress_Report_2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_Progress_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_National_and_Subnational_HIV_Estimates_and_Projections_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_NASA_Report_2016-2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_TB_Global_Report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-Global-AIDS-Update_Asia-Pacific_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-changing-laws-that-discriminate_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/PNG_HIV_National_Strategic_Information_2018-22.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/PNG_National_STI_and_HIV_Strategy.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-young-peoples-participation-in-community-based-responses-to-hiv_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNODC_factsheet_Ending_AIDS_by_2030_for_people_and_with_PUD_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HRI-women-harm-reduction-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Elective_C-section_should_not_be_routinely_recommended_to_WLHIV_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guideline_on_digital_interventions_for_health_system_strengthening_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Progress_report_on_HIV_viral_hepatitis_and_STI_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV_UHC_Guide_Civil_Society_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_Annual_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV-related-travel-restrictions-explainer_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HIV-and-the-Law-supplement-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_IBBS_and_Population_size_estimates_among_FSW_2015.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
Calendar of events
Mar
1
(1 Mar - 1 Mar)
Mar
3
Mar
8
(8 Mar - 8 Mar)